Stay updated with breaking news from Scribe Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The pharmaceutical industry has experienced a notable uptick in licensing agreements for innovator drugs incorporating clustered regularly interspaced short palindromic repeats (CRISPR)-based technology over the past five years. These agreements, primarily concentrated in oncology, immunology, and central nervo...
Intra-Cellular Therapies (NASDAQ:ITCI – Get Free Report) and Sanofi (NASDAQ:SNY – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, analyst recommendations, profitability, risk, earnings, dividends and institutional ownership. Analyst Ratings This is a breakdown of current recommendations […]
The Jan. 20 event at UC Berkeley's Zellerbach Hall will host several speakers chronicling how small changes led to big outcomes.
Scribe Therapeutics Inc. announced that Sanofi has exercised its option for a second target as part of the companies' research collaboration to develop in vivo CRISPR-based therapeutics. CRISPR by...
"The European market is the second-largest gene therapy market globally, mainly due to factors such as advancements in targeted therapy research and government support."Gene Therapy Market in terms of revenue was